(Total Views: 102)
Posted On: 09/10/2020 12:34:22 PM
Post# of 94311
$QBIO Q BioMed featured in this Biopharma Update on the Novel Coronavirus: https://www.biospace.com/article/biopharma-up...TrackID=16
Q BioMEd, with its technology partner Mannin Research, announced a GMP production contract had been initiated for MAN-19, a clinical grade therapeutic to treat complications caused by COVID-19. The Phase I trial is expected to begin enrolling patients in February 2021.
Q BioMEd, with its technology partner Mannin Research, announced a GMP production contract had been initiated for MAN-19, a clinical grade therapeutic to treat complications caused by COVID-19. The Phase I trial is expected to begin enrolling patients in February 2021.
(0)
(0)
